cabergoline has been researched along with von Hippel-Lindau Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cottier, JP; François, P; Gilbert-Dussardier, B; Girard, JJ; Jan, M; Lecomte, P; Richard, S; Trouillas, J; Tudorancea, A | 1 |
1 other study(ies) available for cabergoline and von Hippel-Lindau Disease
Article | Year |
---|---|
Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy.
Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Ergolines; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Mutation; Pituitary Neoplasms; Prolactin; Somatostatin; Treatment Outcome; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2012 |